How did Corona vaccines appear so quickly?

In the midst of the search for a vaccine to end the emerging coronavirus, many are concerned about the great speed that has resulted in effective vaccines against the epidemic that has claimed the lives of more than one million and 700 thousand people around the world. .

Experts are divided among those who believe that the nature of the epidemic, which appeared in December 2019, required a high-speed movement to adopt vaccines against Covid-19, while one team believes that what has been achieved lacks additional experience. similar to previous vaccines that have been invented by mankind and have proven useful. Eliminate a number of diseases or drastically reduce the number of infections.

Regarding the reasons that made us obtain the anti-corona vaccines so quickly, the British newspaper “The Guardian” published a report highlighting 9 reasons for this, based on the opinions of specialists:

Advance plan

Before the outbreak of the pandemic, there was a global awareness about the possibility of an epidemic, and governments, institutions and international organizations worked to collect resources for it, and launched initiatives that favor this trend, such as the International Alliance for Innovations in Epidemic Preparedness in 2017.

Similarly, companies and universities such as “Biontech”, “Moderna” and “Oxford” have been developing modern technologies aimed at producing vaccines based on the genetic codes of infectious pathogens, which have been tested for years.

Move early in China

Despite all the rumors about China’s delay in detecting the virus, scientists at Fudan University in Shanghai diagnosed cases of Covid-19 in its early stages, quickly revealed the genetic sequence of the virus’s RNA, and made this known. information to the public, which contributed to the investigation carried out later. Develop anti-vaccines and accelerate their production.

Great fast finances

Vaccine developers obtained large and immediate funds motivated by confronting Covid-19, which terrorized the world and caused unprecedented paralysis and great economic losses, while previous financing operations required convincing funders, be they agencies, associations or individuals.

Accelerate clinical trials

The processes for writing clinical trial protocols and obtaining approvals for their implementation have been accelerated.

Start vaccine trials immediately

Supervisors of the vaccine trials were able to do it right away. In Britain, for example, there were four centers ready to start studying the “Oxford” vaccine, and the National Institute for Health Research identified 14 additional sites and prepared for the later stages of the studies.

Ease of sharing information

Modern technology has contributed to the exchange and collection of information very quickly, in addition to reducing the possibility of error and the exchange of data for immediate analysis.

Large number of volunteers

The vaccine studies and trials were very popular with volunteers and participants, saving the time previously spent recruiting them.

Quick success

The first vaccines worked well in a short time, to demonstrate their benefit in facing the pandemic, although relatively, pending the final judgment that will be issued on these vaccines after a longer period of time.

Studies continue

With the epidemic, a different approach was taken with regard to regulatory approvals, as it is common for all experimental results and data to be prepared in one huge package once studies are completed, a process that takes months.

The entire group then goes to regulators, the agencies that license drugs and vaccines, to begin reviewing them, in another process that takes months.

But what is different about Corona vaccines is that the data was submitted to regulatory bodies during their creation and was reviewed during the continuation of the studies, and when the final results appeared, these were the only results left for review.